| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/09/2005 | EP1511376A2 Transgenic zebrafish models for thrombosis |
| 03/09/2005 | EP1392354B1 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic wounds |
| 03/09/2005 | EP1242825B1 Extraction of lipoproteins from body fluids |
| 03/09/2005 | EP1237916B1 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 03/09/2005 | EP1233783B1 Hbv/hcv virus-like particle |
| 03/09/2005 | EP1230344A4 Plant biochemistry-related genes |
| 03/09/2005 | EP1230256A4 Plant developmental genes |
| 03/09/2005 | EP1159423B1 Uses of transgenic animals containing a type x collagen mutant |
| 03/09/2005 | EP1116033A4 Diagnostic assays for detection of cryptosporidium parvum |
| 03/09/2005 | EP1115277A4 Novel method of regulating seed development in plants and genetic sequences therefor |
| 03/09/2005 | EP1108026B1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 03/09/2005 | EP1021460A4 Laminins and uses thereof |
| 03/09/2005 | EP1006780A4 Two component plant cell lethality methods and compositions |
| 03/09/2005 | EP0938556B1 Gamma-heregulin |
| 03/09/2005 | EP0932613B1 Blocking expression of virulence factors in s. aureus |
| 03/09/2005 | EP0876612B1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
| 03/09/2005 | EP0845943B1 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits |
| 03/09/2005 | EP0842273B1 Receptor ligand vegf-c |
| 03/09/2005 | EP0784481B1 Wound healing formulations containing human plasma fibronectin |
| 03/09/2005 | EP0763113B1 Genetic sequences conferring disease resistance in plants and uses therefor |
| 03/09/2005 | EP0756005B1 Gene coding for adseverin |
| 03/09/2005 | CN1592794A Cell culture system for synthesis of infectious hepatitis C virus |
| 03/09/2005 | CN1592793A Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 03/09/2005 | CN1592786A Methods and compositions for highly efficient production of heterologous proteins in yeast |
| 03/09/2005 | CN1592755A Anti-angiogenic peptides |
| 03/09/2005 | CN1592753A Methods for preparing purified daptomycin |
| 03/09/2005 | CN1592751A Nucleic acids encoding a recombinant 250 kDa antigen from sporozoites/merozoites of eimeria maxima and their uses |
| 03/09/2005 | CN1592720A Metal binding proteins and associated methods |
| 03/09/2005 | CN1592638A Promoters exhibiting endothelial cell specificity and methods of using same |
| 03/09/2005 | CN1592637A Medicinal compositions |
| 03/09/2005 | CN1592636A Immunotherapeutic combinations for the treatment of tumors |
| 03/09/2005 | CN1592635A Autologous growth factor cocktail composition, method of production and use |
| 03/09/2005 | CN1592634A Non-neurotoxic plasminogen activating factors for treating stroke |
| 03/09/2005 | CN1592588A Necktie wearing unit |
| 03/09/2005 | CN1592576A Disruption of the prostaglandin E synthase 2 gene |
| 03/09/2005 | CN1590551A Optimization of cell for endogenous gene activation |
| 03/09/2005 | CN1590543A Thermostable Taq polymerase fragment |
| 03/09/2005 | CN1590408A Preparation technology of globe fish peptide and its medical health care use |
| 03/09/2005 | CN1590407A Multifunctional blood forming receptor agonist |
| 03/09/2005 | CN1590406A Peptide of specific combined ricin, its coding nucleic acid and method of detecting and inhibiting ricin |
| 03/09/2005 | CN1590405A White candidas transcription factor gene and its use |
| 03/09/2005 | CN1590404A Antigenic meningococcal peptides |
| 03/09/2005 | CN1590400A Heavy chain and light chain sariable region gene of anti eel vibrion unique single clone antibody |
| 03/09/2005 | CN1589908A Tenascin-C nucleic acid ligands |
| 03/09/2005 | CN1589902A Application of anti-lymphotoxin-beta receptor antibodies in preparation of medical composition |
| 03/09/2005 | CN1589901A Foot and mouth disease bivalent polypeptide vaccine and its preparation method and use |
| 03/09/2005 | CN1589899A Application of recombination now type composite interferon in preventing and treating SARS |
| 03/09/2005 | CN1192236C In vitro method for determining presence of protein in separated biological sample |
| 03/09/2005 | CN1192111C Method for production of proteinaceous substances |
| 03/09/2005 | CN1192109C Anticoagulant fusion protein anchored to cell membrane |
| 03/09/2005 | CN1192107C 5S clavate alkyl gene separated from rhabdion streptomycete and its application in clavulanic acid production |
| 03/09/2005 | CN1192106C Novel method to isolate mutants and to clone the complementing gene |
| 03/09/2005 | CN1192105C A variant of C6 beta-chemokine leukotactin-1(shLKn-1) with enhanced biological activity |
| 03/09/2005 | CN1192104C Use of alpha-1,4-glucan lyase for preparation of 1,5-D-anhydrofructose |
| 03/09/2005 | CN1192101C Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 03/09/2005 | CN1192038C Monoclonal antibodies against HIV-1 and vaccines made thereof |
| 03/09/2005 | CN1192037C Signal sequence for production of leu-hirudine via secretion by E coli in culture medium |
| 03/09/2005 | CN1192011C Calcium receptor-active arylalkyl amines |
| 03/09/2005 | CN1191864C Hemoglobin-polysaccharide conjugates |
| 03/09/2005 | CN1191858C Method for inhibiting brain tnmor growth |
| 03/09/2005 | CN1191855C Remedies for lymphocytic tumors |
| 03/09/2005 | CN1191852C Vaccine |
| 03/09/2005 | CN1191851C Polypeptide comprising amino acid of AN N-terminal choline binding protein truncate, vaccine derived therefrom and uses thereof |
| 03/09/2005 | CN1191754C Preserving hemoglobin blood substitute with transparent overwrap |
| 03/08/2005 | US6865492 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
| 03/08/2005 | US6864365 Bacterial fimbrial system for presentation of heterologous peptide sequences |
| 03/08/2005 | US6864364 MinK-related genes, formation of potassium channels and association with cardiac arrhythmia |
| 03/08/2005 | US6864362 Hypoallergenic transgenic soybeans |
| 03/08/2005 | US6864359 Structure-based screening techniques for drug discovery |
| 03/08/2005 | US6864358 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 03/08/2005 | US6864356 Amino acid sequence of pyroglutamyl-leucinyl-lysinyl-cysteinyl-tyrosinyl-threoninyl-cysteinyl -lysinyl-gluta myl-prolinyl-methioninyl-threoninyl-serinyl-alaninyl-alaninyl-cysteine, in a peptide, is used as antitumor agent |
| 03/08/2005 | US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| 03/08/2005 | US6864239 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions |
| 03/08/2005 | US6864238 Methods and compositions for destabilizing microtubules |
| 03/08/2005 | US6864235 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 03/08/2005 | US6864234 Somatostatin agonists |
| 03/08/2005 | US6864229 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 03/08/2005 | US6864227 Artery-and vein-specific proteins and uses therefor |
| 03/08/2005 | US6864226 Endothelial-monocyte activating polypeptide III |
| 03/08/2005 | US6864083 Expression vectors; use in identifying compound that modulates receptor activated calcium mobilization |
| 03/08/2005 | US6864082 Modified viral surface proteins for binding to extracellular matrix components |
| 03/08/2005 | US6864076 Protein for use in the prevention of fungal infection |
| 03/08/2005 | US6864069 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 03/08/2005 | US6864068 Mutant plant |
| 03/08/2005 | US6864067 Compositions and methods for regulating bacterial pathogenesis |
| 03/08/2005 | US6864066 Epithelial protein lost in neoplasm (EPLIN) |
| 03/08/2005 | US6864062 Purified antigen for Alzheimer's disease and methods of obtaining and using same |
| 03/08/2005 | US6864060 Yeast cells expressing modified G proteins and methods of use therefor |
| 03/08/2005 | US6864055 Method for detecting nucleic acids |
| 03/08/2005 | US6864054 Polypeptides from CREB binding protein and related protein p300 for use in transcriptional regulation |
| 03/08/2005 | US6863894 Mutant Salmonella; anticancer agents |
| 03/08/2005 | US6863893 Vaccination of mammals with pneumococcal derived polypeptides that include an alpha helix but exclude a choline binding region as a mechanism for stimulating production of an antibody that protects vaccine recipient from infection |
| 03/08/2005 | US6863892 Diagnosi and treatment of cancer; obtain tissue sample, monitor gene expression in sample, monitor methylation in sample, compare to control, evaluate for cancer |
| 03/08/2005 | US6863889 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, immune, autoimmune, bone, nervous system, inflammatory and skin disorders |
| 03/08/2005 | US6863887 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
| 03/08/2005 | US6863881 Compositions and methods of nematode control |
| 03/08/2005 | CA2106960C Plant promoter involved in controlling lipid biosynthesis in seeds |
| 03/06/2005 | WO2005051991A2 Mucin antigen vaccine |
| 03/06/2005 | CA2544946A1 Mucin antigen vaccine |
| 03/03/2005 | WO2005019831A2 Methods for reducing complexity of a sample using small epitope antibodies |